Tempest Therapeutics (TPST) Earnings Date, Estimates & Call Transcripts $6.79 -0.08 (-1.16%) Closing price 05/13/2025 04:00 PM EasternExtended Trading$7.15 +0.36 (+5.30%) As of 07:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tempest Therapeutics Earnings Summary Tempest Therapeutics posted Q1 2025 earnings on May 13, 2025, reporting an EPS of -$3.16, which missed the consensus estimate of -$0.31 by $2.85. With a trailing EPS of -$19.51, Tempest Therapeutics' earnings are expected to grow next year, from ($1.39) to ($1.05) per share. Latest Q1 Earnings DateMay. 13EstimatedConsensus EPS (May. 13) -$0.31 Actual EPS (May. 13) -$3.16 Missed By -$2.85 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Tempest Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tempest Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTPST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Tempest Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$4.42-$4.03-$4.23Q2 20251-$4.55-$4.55-$4.55Q3 20251-$4.94-$4.94-$4.94Q4 20251-$5.46-$5.46-$5.46 Tempest Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025-$0.31-$3.16 -$2.85-$3.16--3/27/2025Q4 2024-$3.12-$4.03 -$0.91-$0.31-$0.49M11/12/2024--$4.81-$5.33 -$0.52-$0.41--8/8/2024--$6.11-$5.46+$0.65-$0.42--5/9/2024Q1 2024-$5.72-$4.68+$1.04-$0.36--3/19/2024Q4 2023-$4.94-$4.42+$0.52-$0.34--11/8/2023Q3 2023-$7.15-$6.24+$0.91-$0.48--8/10/2023Q2 2023-$7.54-$7.02+$0.52-$0.54-- Tempest Therapeutics Earnings - Frequently Asked Questions When did Tempest Therapeutics announce their last quarterly earnings? Tempest Therapeutics (NASDAQ:TPST) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on TPST's earnings history. Did Tempest Therapeutics beat their earnings estimates last quarter? In the previous quarter, Tempest Therapeutics (NASDAQ:TPST) missed the analysts' consensus estimate of ($0.31) by $2.85 with a reported earnings per share (EPS) of ($3.16). Learn more on analysts' earnings estimate vs. TPST's actual earnings. How much profit does Tempest Therapeutics generate each year? Tempest Therapeutics (NASDAQ:TPST) has a recorded net income of -$29.49 million. TPST has generated -$19.51 earnings per share over the last four quarters. What is Tempest Therapeutics's EPS forecast for next year? Tempest Therapeutics's earnings are expected to grow from ($1.39) per share to ($1.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies MacroGenics Earnings Date Black Diamond Therapeutics Earnings Date Contineum Therapeutics Earnings Date Entera Bio Earnings Date Kyverna Therapeutics Earnings Date OptiNose Earnings Date HilleVax Earnings Date Immunic Earnings Date Cardiol Therapeutics Earnings Date Zentalis Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming? This page (NASDAQ:TPST) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersAI Boom Takes a Shocking Turn…The AI “Gold Rush” is Here… History's repeating itself — but this time, the shovels are digital. Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Musk’s Next Big BetCancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
